home / stock / inbp / inbp quote
Last: | $0.215 |
---|---|
Change Percent: | 16.0% |
Open: | $0.1806 |
Close: | $0.215 |
High: | $0.215 |
Low: | $0.1806 |
Volume: | 600 |
Last Trade Date Time: | 04/09/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.215 | $0.1806 | $0.215 | $0.215 | $0.1806 | 600 | 04-09-2024 |
$0.22 | $0 | $0.22 | $0 | $0 | 1 | 04-08-2024 |
$0.22 | $0.22 | $0.22 | $0.22 | $0.22 | 1,000 | 04-05-2024 |
$0.19 | $0.19 | $0.19 | $0.21 | $0.19 | 29,499 | 04-04-2024 |
$0.22885 | $0.1926 | $0.22885 | $0.22885 | $0.1926 | 2,501 | 04-03-2024 |
$0.2196 | $0.2196 | $0.2196 | $0.2196 | $0.2196 | 1,000 | 03-27-2024 |
$0.2196 | $0.2196 | $0.2196 | $0.2196 | $0.2196 | 5,000 | 03-26-2024 |
$0.2296 | $0.21 | $0.2296 | $0.2296 | $0.1926 | 9,000 | 03-22-2024 |
$0.2185 | $0.2026 | $0.2185 | $0.2185 | $0.2026 | 700 | 03-13-2024 |
$0.2296 | $0 | $0.2296 | $0 | $0 | 13 | 03-07-2024 |
$0.2296 | $0.2296 | $0.2296 | $0.2296 | $0.2296 | 2,178 | 03-06-2024 |
$0.2296 | $0.22664 | $0.2296 | $0.2296 | $0.2015 | 8,400 | 03-01-2024 |
$0.2196 | $0.1806 | $0.2196 | $0.2196 | $0.1806 | 1,400 | 02-29-2024 |
$0.2197 | $0.2197 | $0.2197 | $0.2197 | $0.2197 | 100 | 02-27-2024 |
$0.2299 | $0.21 | $0.2299 | $0.2299 | $0.1805 | 31,000 | 02-14-2024 |
$0.2 | $0.21 | $0.2 | $0.2399 | $0.19 | 14,150 | 02-13-2024 |
$0.23 | $0.215 | $0.23 | $0.23 | $0.215 | 32,200 | 02-09-2024 |
$0.21805 | $0 | $0.21805 | $0 | $0 | 65 | 02-08-2024 |
$0.21805 | $0.21805 | $0.21805 | $0.21805 | $0.21805 | 200 | 02-07-2024 |
$0.200525 | $0.2135 | $0.200525 | $0.22 | $0.200525 | 35,200 | 02-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Integrated Biopharma Inc Company Name:
INBP Stock Symbol:
OTCMKTS Market:
HILLSIDE, NJ / ACCESSWIRE / February 12, 2024 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended December 31, 2023. Revenue for the quarter ended December 31, 2023 was $11.5 million compared to $12.3 million for the quarter ...
Asics Corporation ADR (ASCCY) is expected to report for quarter end 2023-12-31 W. P. Carey Inc. REIT (WPC) is expected to report $1.16 for Q4 2023 Core Scientific, Inc. (CORZQ) is expected to report for Q4 2023 Essent Group Ltd. (ESNT) is expected to report $1.59 for Q4 2023 SAAB ...
HILLSIDE, NJ / ACCESSWIRE / November 9, 2023 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter ended September 30, 2023. Revenue for the quarter ended September 30, 2023 was $12.9 million compared to $12.3 million for the quarter e...